TreatmentMagnetic resonance imagingLaboratory testsThe diagnosis of multiple sclerosis (MS) still rests on the time-honored twin criteria of dissemination in time and space. The disease shows a predilection for
There are four different types of multiple sclerosis that have been identified and each type can have symptoms ranging from mild to severe. The different types of MS can help predict the course of the disease and a patient's response to treatment. The four types of MS are discussed on the ...
Multiple sclerosis (MS) is thought to be an autoimmune disease; however, the exact cause is not known. Early signs and symptoms of MS are fatigue, bladder and bowel problems, vision problems, and numbness, tingling, or pain in certain areas of the body.
Cognitive impairment is a common and devastating manifestation of multiple sclerosis (MS). Although disease-modifying therapies have been efficacious for reducing relapse rates in MS, such treatments are ineffective for treating cognitive dysfunction. Alternative treatment approaches for mitigating cognitive pr...
The modern treatment era formultiple sclerosis(MS) began in 1993 with the approval of the first disease-modifying agent. Since then the field has greatly expanded, with 10 therapies currently approved to treatMS. These treatments are effective to reduce relapses and changes on MRI, and slow dis...
Box 1 Current treatment strategies for multiple sclerosis: too little, too late? The choice of therapeutic for individual patients depends on disease activity (for example, the number of relapses and lesion formation) and patient characteristics (for example, age, sex, concomitant diseases and their...
Multiple sclerosis (MS) has a worldwide distribution but is five times more common in temperate regions than in tropical regions. Thediseaseprimarily occurs in individuals between ages 20 and 40, and women are affected by the disease more often than men. ...
an Open Access Journal by MDPI 2.7 4.8 The Biomarkers, Symptoms, and Treatment of Multiple Sclerosis Guest Editor: Dr. Clara Grazia Chisari Department of Systems Medicine, Università degli Studi di Roma "Tor Vergata", Rome, Italy Deadline for manuscript submissions: closed (30 November 2024) ...
Although there isn't yet a cure for multiple sclerosis, the many new treatment options around DMTs, better supportive care, and earlier detection have led to greatly improved outcomes for people with MS. However, the biggest challenges doctors face in treating MS are the health risks associated ...
Appropriate multiple sclerosis (MS) therapy selection is critical to maximize patient benefit. The current guidelines review the scientific evidence supporting current therapies and provide recommendations for treatment of acute relapses, clinically isolated syndrome, relapsing remitting MS, secondary progressive...